К содержанию
Dr. Tara EinullaevaMedical oncologist

Cancer glossary

Squamous cell carcinoma on a pathology report: what it means

Squamous cell carcinoma is cancer of flat squamous cells. How it is written on a report, what ‘keratinizing’ and G1–G3 mean, and how it shapes treatment.

Written and medically reviewed by

Dr. Tara Einullaeva

Medical oncologist, 9 years in practice. Credentials · reviewed 17 October 2026

In short

Squamous cell carcinoma is a malignant tumor of squamous cells, thin flat cells that line the skin and the mucous membranes of several organs. It occurs in the skin, lung, esophagus, cervix and other organs, and in each one it is a separate disease with its own treatment.

How it appears in your report

  • ‘Keratinizing squamous cell carcinoma, moderately differentiated (G2)’.
  • ‘Non-keratinizing squamous cell carcinoma’ — a subtype that does not make keratin.
  • ‘Squamous cell carcinoma in situ’ — the tumor cells have not spread beyond the epithelium; see carcinoma in situ.
  • ‘Invasive squamous cell carcinoma’ — the tumor has grown into the tissue below.

IHC results are often listed alongside: they help tell squamous cell carcinoma apart from other tumors when the type is not clear on routine staining.

What it means

Squamous cell carcinoma is a type of carcinoma, like adenocarcinoma, but it starts in different cells. Examples from the American Cancer Society:

Organ What is known
Cervix up to 9 out of 10 cervical cancers are squamous cell carcinomas
Esophagus most common in the middle part; the most common type of esophageal cancer in many parts of the world
Lung usually in the central part of the lung, near a main airway; often linked to smoking

The grade (G1–G3) shows how different the cells look from normal ones. It is not the stage.

Does it affect treatment

Yes. Squamous cell carcinoma and adenocarcinoma of the same organ are often treated differently: drug regimens, molecular testing, and the role of radiation and chemoradiation may all differ. In advanced disease, PD-L1 may be tested to help choose immunotherapy. The actual plan depends on the organ, the stage and your overall health, and is discussed with your treating doctor or tumor board.

Questions to ask your doctor

  • Is the tumor type final, or is IHC needed to confirm it?
  • Which tests are needed for squamous cell carcinoma at my tumor site (for example, PD-L1)?
  • What roles do drug treatment, surgery and radiation play in my plan?

Sources

  1. What Is Cancer? — National Cancer Institute (NCI), 2026
  2. What Is Cervical Cancer? — American Cancer Society, 2025
  3. What Is Cancer of the Esophagus? — American Cancer Society, 2025
  4. What Is Lung Cancer? — American Cancer Society, 2024

FAQ

Related terms

This is reference information and not a substitute for medical advice. Your doctor interprets each value in the context of your whole situation.

Related articles

All blog articles